Literature DB >> 22532550

Valproic acid enhances glucose transport in the cultured brain astrocytes of glucose transporter 1 heterozygous mice.

Sung-Koo Kim1, Hong Yang, Juan M Pascual, Darryl C De Vivo.   

Abstract

Glucose transporter 1 facilitates glucose transport across the blood-brain barrier. By increasing histone acetylation at the SLC2A1 promotor, valproic acid could increase SLC2A1 gene expression. This study was designed to evaluate the effects of valproic acid on glucose transport in astrocyte cultures derived from SLC2A1 heterozygous mice. Primary astrocyte cultures were prepared from the cerebral cortex of 1-day-old neonatal mice. Cultured astrocytes were incubated with valproic acid (0.05, 0.5, and 5 mM) for 48 hours. On day 3, the glucose uptake capacity of the astrocytes was measured by using (14)C-2-Deoxy-d-glucose under zero-trans conditions. The heterozygous astrocyte glucose uptake treated with valproic acid (0.05 and 0.5 mM) for 48 hours was significantly increased compared with the untreated control heterozygous astrocytes. Our findings demonstrate that valproic acid increased glucose transport capacity in SLC2A1 heterozygous cerebral astrocytes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22532550     DOI: 10.1177/0883073812440044

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  4 in total

1.  miR-29c-5p knockdown reduces inflammation and blood-brain barrier disruption by upregulating LRP6.

Authors:  Qijun Dai; Jian Sun; Tianyi Dai; Qin Xu; Yueqin Ding
Journal:  Open Med (Wars)       Date:  2022-02-22

2.  Clinical Aspects of Glucose Transporter Type 1 Deficiency: Information From a Global Registry.

Authors:  Jian Hao; Dorothy I Kelly; Jianzhong Su; Juan M Pascual
Journal:  JAMA Neurol       Date:  2017-06-01       Impact factor: 18.302

Review 3.  Glucose Transporter Type I Deficiency (G1D) at 25 (1990-2015): Presumptions, Facts, and the Lives of Persons With This Rare Disease.

Authors:  Juan M Pascual; Gabriel M Ronen
Journal:  Pediatr Neurol       Date:  2015-08-10       Impact factor: 3.372

Review 4.  Epigenetics in blood-brain barrier disruption.

Authors:  Stephanie A Ihezie; Iny Elizebeth Mathew; Devin W McBride; Ari Dienel; Spiros L Blackburn; Peeyush Kumar Thankamani Pandit
Journal:  Fluids Barriers CNS       Date:  2021-04-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.